Drug Topics
APRIL 14, 2023
Over 400 pharmaceutical employees and executives signed an open letter in a show of solidarity with the FDA, but some say that big pharma’s actions helped lead to this moment in the first place.
PhRMA
APRIL 14, 2023
As part of the implementation of the Inflation Reduction Act (IRA), the Centers for Medicare & Medicaid Services (CMS) issued draft guidance on the process for setting the price of medicines. The process is in no way a “negotiation,” and CMS chose to go beyond what was outlined in the statute, taking the most extreme stance to sweep in as many medicines as possible and be as punitive as possible.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
APRIL 14, 2023
Four independent pharmacists shared their journeys to become pharmacy owners.
Pharmacy Times
APRIL 14, 2023
Based on the study results, investigators concluded that there is justification for a randomized clinical trial.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
APRIL 14, 2023
HHS Secretary Xavier Becerra will release an amendment to the declaration in the coming weeks.
STAT
APRIL 14, 2023
Black people in counties with more Black primary care physicians live longer, according to a new national analysis that provides the strongest evidence yet that increasing the diversity of the medical workforce may be key to ending deeply entrenched racial health disparities. The study , published Friday in JAMA Network Open, is the first to link a higher prevalence of Black doctors to longer life expectancy and lower mortality in Black populations.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
APRIL 14, 2023
On most days around 2pm, home health aide Duane Crichlow can be found in an apartment in Sunset Park, Brooklyn, playing catch with his client — a man in his 30s with a developmental disability who is quick to give Crichlow hugs and kisses. If it’s nice outside, Crichlow will walk his client, who is nonverbal and in a wheelchair half the time, down three flights of stairs, hauling the wheelchair back and forth separately.
Drug Topics
APRIL 14, 2023
Your weekly roundup of the latest news from Drug Topics®.
Fierce Healthcare
APRIL 14, 2023
Google, Microsoft and startups test out generative AI in healthcare hlandi Fri, 04/14/2023 - 08:04
Drug Topics
APRIL 14, 2023
Pharmacists need a depth and breadth of knowledge to get the most out of point-of-care testing for sexually transmitted infections.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
APRIL 14, 2023
Being observant and knowing how to ask screening questions are critical to identifying red flags.
Drug Topics
APRIL 14, 2023
From explaining how medications work and should be taken to reviewing potential adverse effects and financial details, pharmacists are crucial resources for patients undergoing treatment for skin cancer.
Fierce Healthcare
APRIL 14, 2023
About 800,000 nurses planning to leave the profession by 2027, data show dmuoio Fri, 04/14/2023 - 14:25
Drug Topics
APRIL 14, 2023
Daprodustat increases erythropoietin production, leading to an increase in the production of red blood cells.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmaVoice
APRIL 14, 2023
A serial entrepreneur, futurist and industry disrupter, the VP of clinical development and digital health is always on the quest to build a “better mousetrap.
Fierce Healthcare
APRIL 14, 2023
Humana puts $40M toward affordable housing pminemyer Fri, 04/14/2023 - 15:52
Pharmacy Times
APRIL 14, 2023
The Aquilino Cancer Center established the Bill Richards Center for Healing inside the same building, so patients with cancer can receive psychedelic-assisted therapy in the same location as their cancer care.
Fierce Healthcare
APRIL 14, 2023
Fitch Ratings says Medicaid disenrollment will pinch revenue for not-for-profit hospitals fdiamond Fri, 04/14/2023 - 14:26
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
APRIL 14, 2023
41% of patients report moderate-to-severe issues, with Black individuals 3 times more likely to develop these difficulties.
Fierce Healthcare
APRIL 14, 2023
Spring forward: Mental health benefits company nabs $71M, propels to $2.
Pharmacy Times
APRIL 14, 2023
Establish procedures, including training employees, to address shortages, back-order situations.
Pharmafile
APRIL 14, 2023
Pharma giant Eli Lilly’s Biologic Licence Application (BLA) for its bowel disease drug has been declined by the FDA over concerns about the proposed manufacturing of the drug. However, concerns weren’t expressed over the clinical data package, safety or label for the medicine. Mirikizumab was hoped to become a new drug treatment for ulcerative colitis (UC), a condition where abnormal reactions in the immune system cause inflammation in the inner lining of the colon.
Pharmaceutical Technology
APRIL 14, 2023
Clinical-stage biopharmaceutical company TORL BioTherapeutics has raised $158m in a Series B financing round for advancing the development of new biologics for cancer treatment. TORL BioTherapeutics is a newly formed, US-based company focused on the development of novel antibody-based therapeutics for cancer patients. Led by Goldman Sachs Asset Management, the financing round has also seen participation from Deep Track Capital, Moore Strategic Ventures, Cowen Healthcare Investments, Bristol Myer
Drug Store News
APRIL 14, 2023
The NACDS Foundation is awarding $1 million in grants in support of two innovative research projects.
Pharmaceutical Technology
APRIL 14, 2023
Ginkgo Bioworks (Ginkgo) and the Wisconsin Alumni Research Foundation (WARF) have collaborated to discover next-generation GD2 CAR T-cell therapies to treat solid tumours. WARF is the patenting and licensing organisation for the University of Wisconsin–Madison in the US. Ginkgo will partner with researchers from Wisconsin-Madison to discover new and improved GD2 CAR designs with improved persistence, fitness and proliferation.
Drug Store News
APRIL 14, 2023
Following Walgreens' recent acquisitions of CareCentrix and Shields Health Solutions, leaders from the companies discussed how they are working to change the patient experience.
Fierce Healthcare
APRIL 14, 2023
UnitedHealth Group execs bullish on Medicare Advantage growth amid risk adjustment overhaul pminemyer Fri, 04/14/2023 - 07:47
STAT
APRIL 14, 2023
For 10 years, I have depended on Adderall to help me function. But in February, for the first time, the pharmacy down the street was unable to fill my prescription. In fact, 19 pharmacies in a row told me that they were out of stock. Thankfully, the 20th was able to fill it — though it meant a 50-minute drive. The quest to find my daily medication left me struggling to function and feeling utterly helpless.
Fierce Healthcare
APRIL 14, 2023
UPMC taking major steps to tackle climate change.
The Checkup by Singlecare
APRIL 14, 2023
Losing weight is a marathon, not a sprint—a long and arduous marathon, sometimes, depending on how much weight you want to lose, and many people look for medications to aid in the process. Take stimulant medications for conditions like attention-deficit/hyperactivity disorder (ADHD) or narcolepsy, for example. Since weight loss is often noted as a possible side effect, some people try to use stimulants like Adderall (amphetamine/dextroamphetamine) to reach their weight loss goals.
Fierce Healthcare
APRIL 14, 2023
Gender pay gap narrowing among physicians, particularly in primary care, new Medscape survey finds agliadkovskaya Fri, 04/14/2023 - 12:01
Drug Store News
APRIL 14, 2023
The new program rewards customers for staying active with points redeemable for grocery coupons and discounts.
Pharmaceutical Technology
APRIL 14, 2023
The US Food and Drug Administration (FDA) has granted rare paediatric drug designations for IPS HEART’s stem cell therapeutics, GIVI-MPC and ISX9-CPC, to treat Duchenne muscular dystrophy (DMD) patients. GIVI-MPC is intended to create new skeletal muscle with 100% full-length dystrophin, while ISX9-CPC is designed to create new functional cardiac muscle for indicated patients.
Expert insights. Personalized for you.
469 
Let's personalize your content